Transfusion medicine

Canadian Blood Services supports best practices in transfusion medicine through the development of educational resources. Written by subject-matter experts from across Canada, our transfusion medicine resources support clinical practice and help health-care professionals stay current in an ever-changing field.

If you are a health-care professional working in transfusion medicine and have a comment or suggestions for new resources, please get in touch.

Image
A smiling woman with dark hair wearing a black shirt.

Aditi Khandelwal
Transfusion Medicine Specialist and Hematologist

Access the Canadian Recipient Hemovigilance System Renewal Process Recommendations paper, shared with the transfusion community to support transparency and broad awareness of the engagement outcomes.
According to Blood Regulations, hospitals are required to report adverse transfusion reactions following a transfusion to Canadian Blood Services if the reaction is thought to be caused by a blood component deficiency affecting its safety, and is attributable to a regulated activity at Canadian Blood Services (e.g., donor selection, blood collection, manufacturing).
Canadian Blood Services, in collaboration with Héma-Québec, developed The Canadian Guidelines for the Uniform Labelling of Blood and Blood Components Using ISBT 128 to assist with the use of ISBT 128 labelling for Canadian Blood Services and Héma-Québec. This document describes the standard policies adopted for use by Canadian Blood Services and Héma-Québec and is intended to be used in conjunction with the ISBT 128 Standard: Technical Specification.